PER-021-00未知未知
IN VITRO SUSCEPTIBILITY OF MOXIFLOXACIN OF THE MOST COMMON PATHOGENS OF THE RESPIRATORY SYSTEM REGIONAL STUDY IN LATIN AMERICA
BAYER S.A.,0 个研究点目标入组 0 人开始时间: 2000年4月4日最近更新:
试验速览
- 阶段
- 未知
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Investigating the effect of moxifloxacin in Helicobacter infectioIRCT20240128060832N1Ahvaz University of Medical Sciences246
进行中（未招募）
1 期
Pharmacokinetic evaluation of moxifloxacin administered intravenously and orally in healthy volunteers who have had a gastric bypass.Healthy volunteers who have had a gastric bypass at least 6 months agoEUCTR2010-018628-14-BEniversity Ghent
已完成
不适用
Evaluation of efficacy of moxifloxacin (0.5%) in the treatment of non-perforated bacterial corneal ulcersKeratitisCorneal ulcerISRCTN10323655Rajendra Prasad Centre for Ophthalmic Sciences (India)150
已完成
3 期
Clinical efficacy of Moxifloxacin in the treatment of Bacterial Keratitis: A Randomised Clinical TrialBacterial KeratitisEye - Diseases / disorders of the eyeACTRN12606000406505Centre for Eye Research Australia229
进行中（未招募）
不适用
Pharmacokinetics and safety of moxifloxacin; a dose escalation in patients with tuberculosis - Pharmacokinetics and safety of moxifloxaciMedDRA version: 12.1Level: LLTClassification code 10044755Term: TuberculosisTuberculosisEUCTR2010-023491-25-NLniversity Medical Center Groningen